Trusted by the judiciary, government lawyers, prosecutors, and many leading counsel. Click here to request a subscription.
Trusted by the judiciary, government lawyers, prosecutors, and many leading counsel.
Click here to request a subscription.
Trusted by the judiciary, government lawyers, prosecutors, and many leading counsel. Click here to request a subscription.
or click here to request site subscription to search and view all judgments |
The High Court awarded €26,000 to a patient for the delayed diagnosis of visceral leishmaniasis (VL), which should have been suspected and treated with empirical AmBisome between March 10-14, 2014. The patient, an HIV-positive individual from Spain, was admitted to the hospital with symptoms consistent with hemophagocytic lymphohistiocytosis (HLH) and was treated under the HLH protocol. Despite a lack of substantial improvement and the exclusion of herpes virus type 8 (HHV-8) as a trigger, the hospital failed to consider VL in the differential diagnosis until the patient's transfer to a Spanish hospital, where VL was promptly diagnosed and treated. The court found that earlier suspicion and treatment of VL would have led to symptom improvement within a week and substantial recovery within two weeks, sparing the patient approximately three weeks of severe illness and hospitalisation.
Visceral leishmaniasis (VL), HIV-positive patient, hemophagocytic lymphohistiocytosis (HLH), herpes virus type 8 (HHV-8), empirical AmBisome treatment, delayed diagnosis, High Court judgment, Spain, epidemiological association, hospital admission, medical negligence, general damages, Civil Law (Miscellaneous Provisions) Act 2008, reporting restrictions.
Note: This is intended to be a fair and accurate report of a decision made public by a court of law. Any errors should be notified to the editor and will be dealt with accordingly.
Trusted by the judiciary, government lawyers, prosecutors, and many leading counsel.
Click here to request a subscription.